BYSI Bathi saben saham sajrone rolas wulan pungkasan BeyondSpring Inc

BeyondSpring Inc. (BYSI) is implementing predictive software and laboratory automation to discover molecules targeting lung cancer. Net income per share over the last 12 months (TTM) reflects profit dynamics, while -0.16 shows the current volume of this metric. The firm relies on partnerships with pharma behemoths regarding plinabulin and generates revenue from the procurement of neutropenia drugs by insurance funds.

BYSI (BeyondSpring Inc.) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 10.11.2026

BeyondSpring, Inc. - rincian analitis lan metrik utama (BYSI)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega BeyondSpring Inc.|BYSI - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar BeyondSpring Inc.|BYSI - Nilai Bisnis

- data nilai buku modal saham:

Nilai Buku saben Saham BeyondSpring|BYSI - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku beyondspringpharma.com|BYSI - Aset Perusahaan

- indikator beban utang lan likuiditas:

Utang marang Ekuitas BeyondSpring Inc.|BYSI - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas BeyondSpring Pharma|BYSI - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku BeyondSpring Inc.|BYSI - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan BeyondSpring|Indikator likuiditas cepet beyondspringpharma.com

- indikator pendapatan resik lan kelipatan nilai:

BYSI - Bathi pungkasan|Bathi mangsa ngarep BeyondSpring Inc.|BYSI - Rasio rega pasar marang bathi resik|Pangali Forward P/E BeyondSpring|BYSI - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA BeyondSpring Inc.|BYSI - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BeyondSpring|BYSI - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan beyondspringpharma.com|BYSI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BeyondSpring Inc.

Analisis dhasar perusahaan:BeyondSpring Inc. (BYSI)

BeyondSpring Inc. (BYSI) is developing a specialized oncology drug business utilizing a virtual management model. By analyzing net income per share, an investor can determine the actual earnings remaining per security after all expenses are deducted. This indicator isolates the overall financial result from the impact of the total shares outstanding. For a company utilizing outsourced testing, this metric confirms the efficiency of long-term vendor contracts. Steady growth in this metric indicates the fundamental stability of the operating model.

Analisis perusahaan pesaing